Change in Management

ASSTON PHARMACEUTICALS LIMITED (FORMERLY KNOWN AS ASSTON PHARMACEUTICALS PRIVATE LIMITED) To, Date: 01/10/2026 BSE Limited (BSE Ltd) Listing / Compliance Department, Dalal Street, Mumbai – 400001 BSE Scrip Code: 544445 Subject: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III of the said Regulations, we are pleased to inform you that members of the company have approved the following resolution: 1. Receipt, consideration and adoption of the Audited Standalone financial statements of the Company for the financial year ended March 31, 2026 together with the reports of Board of Directors and of the Auditors thereon. 2. Approved appointment of Mr. Ashish Narayan Sakalkar (DIN: 06601011), Managing Director of the Company, as Director retiring by rotation and re-appointment by the members of the Company pursuant to section 152 (6) of the Companies Act, 2013. (Annexure-A) 3. Approved appointment of M/s Panchal S K & Associates (Peer Review Certificate No. 018089 and Firm Registration No. 145989W) as Statutory Auditors of the Company (Annexure-B). 4. Approved increase in remuneration of Mr. Ashish Narayan Sakalkar (DIN: 06601011), Managing Director of the Company 5. Approved increase in remuneration of Mrs. Saili Jayaram More (DIN: 02691527), Whole-time Director and CEO of the Company; 6. Approved increase in remuneration of Mr. Sachin Chandrakant Badakh (DIN: 08685214), Non- Executive Director of the Company; You are requested to please take note of the same. For Asston Pharmaceuticals Limited Rishi Upadhaya Company Secretary and Compliance Officer A74234 Place: Mumbai Enclosed as above CIN: U24304MH2019PLC324187 Reg. Office- 4th Floor Office No A-431 Balaji Bhavan, Plot No 42a Sector-11 CBD Belapur, Navi Mumbai, Thane, Maharashtra, 400614, India Phone No.: 022-49731419 / 49731411, Email id: aston.tech14@gmail.com/compliance@asstonpharmaceuticals.com Web: www.asstonpharmaceuticals.com ASSTON PHARMACEUTICALS LIMITED (FORMERLY KNOWN AS ASSTON PHARMACEUTICALS PRIVATE LIMITED) Annexure-A SR.NO. Particulars Details 1 Reason for Change viz appointment, Mr. Ashish Narayan Sakalkar(DIN: 06601011), Re-appointment, Resignation, Managing Director, has been re-appointed as removal, death or otherwise Managing Director of the company through members' approval via a shareholder resolution passed in the 7th Annual General Meeting held on 29th September, 2026, and was liable to retire by rotation, being re- appointed in terms of Section 152 (6) of the Companies Act, 2013 2 Term of appointment/reappointment Re-appointed as per the provisions of Section 152(6) of the Companies Act, 2013. 3 Brief profile (in case of appointment) Ashish Narayan Sakalkar aged 50 years is the (In case of Appointment) Managing Director of our Company. He has completed his Master of Science in the year 2001 from the Department of NMU, Jalgaon and PHD from JJT University, and also a Diploma in Regulatory Affairs from the University of Delhi. He has good experience in the field of Industrial Chemistry, Quality Assurance and Regulation. He handles the overall business operations of the company and mainly focuses on business expansion, customer acquisition, and negotiation with suppliers. 4 Disclosure of relationships between Mr. Ashish Narayan Sakalkar (DIN: 06601011) directors (in case of appointment of a is not related to any of the existing directors of director) the Company. 5 Information as required under Circular Mr. Ashish Narayan Sakalkar is not debarred No. LIST/COMP/14/2018-19 and from holding the office of a director by virtue NSE/CML/ 2018/02 dated June 20, of any order by SEBI or any other authority 2018 issued by the BSE and NSE, respectively CIN: U24304MH2019PLC324187 Reg. Office- 4th Floor Office No A-431 Balaji Bhavan, Plot No 42a Sector-11 CBD Belapur, Navi Mumbai, Thane, Maharashtra, 400614, India Phone No.: 022-49731419 / 49731411, Email id: aston.tech14@gmail.com/compliance@asstonpharmaceuticals.com Web: www.asstonpharmaceuticals.com ASSTON PHARMACEUTICALS LIMITED (FORMERLY KNOWN AS ASSTON PHARMACEUTICALS PRIVATE LIMITED) Annexure-B SR.NO. PARTICULARS DETAILS 1 Name of the Internal auditor M/s Panchal S K & Associates. 2 Reason for Change Appointment 3 Date of appointment and terms of 04th September, 2026, by passing a appointment resolution in the meeting of the Board of Directors of the Company and approved by the Members of the Company in 7th Annual General Meeting held on 29th September, 2026. 4 Brief profile M/s. Panchal S K & Associates (est. 2017, ICAI Reg. No. 145989W) is led by founder partner Swati Panchal, a member of ICAI since 2012. The firm comprises professionals focused on adding value to clients’ businesses through technology-driven practices and insights. Its experience spans SMEs and larger corporates across various industries. 5 Disclosure of relationship with directors Not related CIN: U24304MH2019PLC324187 Reg. Office- 4th Floor Office No A-431 Balaji Bhavan, Plot No 42a Sector-11 CBD Belapur, Navi Mumbai, Thane, Maharashtra, 400614, India Phone No.: 022-49731419 / 49731411, Email id: aston.tech14@gmail.com/compliance@asstonpharmaceuticals.com Web: www.asstonpharmaceuticals.com